SCHEMBL5203032

SCHEMBL5203032

CN(C)S(=O)(=O)Nc1cccc(OCC#N)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.48
POLB P06746 1/20 0.48
HPGD P15428 4/20 0.47
AR P10275 1/20 0.46
GAA P10253 1/20 0.44
HSD17B10 Q99714 1/20 0.43
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CACNA1B Q00975 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
RECQL P46063 1/20 0.40
PRMT6 Q96LA8 2/20 0.40
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
CACNA1H O95180 1/20 0.40
BRD4 O60885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5201274 0.85 DRD2 (0.54) HTTPOLBHPGDARHSD17B10
SCHEMBL11154437 0.76 HTT (0.55) HTTGAAHSD17B10PKMSMN1; SMN2
SCHEMBL10133340 0.74 HSD17B10 (0.46) HTTHPGDGAAHSD17B10ALDH1A1
SCHEMBL3064450 0.73 SMN1; SMN2 (0.60) HTTGAAHSD17B10ALDH1A1LMNA
SCHEMBL11161071 0.73 HTT (0.52) HTTHPGDGAAHSD17B10ALDH1A1
SCHEMBL5203397 0.72 NISCH (0.56) AR
SCHEMBL509575 0.72 FFAR1 (0.48) HTTHPGDGAAHSD17B10ALDH1A1
SCHEMBL10821884 0.71 DRD2 (0.55) POLBHPGDARALDH1A1LMNA
Hydrochloric Acid SCHEMBL5201622 0.71 NISCH (0.55) ARLMNA
SCHEMBL1111176 0.70 MAP2K1 (0.53) HTTHPGDCACNA1BCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0887346-B1 N-Phenyl-alkylsulfonamide derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists HOFFMANN LA ROCHE (CH) 2007-12-12 EP disclosed
US-6057349-A ALPHA.SUB.1A/1L AGONISTS USED IN THE TREATMENT OF VARIOUS DISEASE STATES SUCH AS URINARY INCONTINENCE, NASAL CONGESTION, PRIAPISM, DEPRESSION, ANXIETY, DEMENTIA, SENILITY, ALZHEIMER'S, DEFICIENCIES IN ATTENTIVENESS AND COGNITION, AND F. HOFFMAN LA ROCHE AG (CH) 2000-05-02 US disclosed
US-5952362-A INHIBITOR OF GLYCOGEN PHOSPHORYLASE ENZYMETIC ACTIVITY AND GLUCOSE ACITIVITY SYNTEX (U.S.A) INC. (US) 1999-09-14 US disclosed
EP-0887346-A2 Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives, their preparation and their use as alpha1A/1L adrenoceptor agonists F. HOFFMANN-LA ROCHE AG (CH) 1998-12-30 EP disclosed